Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis
- 1.8k Downloads
To investigate if perfusion measured with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can be used to differentiate radiation necrosis from tumor recurrence in patients with high-grade glioma.
The study was approved by the institutional review board and informed consent was obtained from all subjects. 19 patients were recruited following surgery and radiation therapy for glioma. Patients had contrast enhancing lesions, which during the standard MRI examination could not be exclusively determined as recurrence or radiation necrosis. DCE-MRI was used to measure cerebral blood volume (CBV), blood–brain barrier (BBB) permeability and cerebral blood flow (CBF). Subjects also underwent FDG-PET and lesions were classified as either metabolically active or inactive. Follow-up clinical MRI and lesion histology in case of additional tissue resection was used to determine whether lesions were regressing or progressing.
Fourteen enhancing lesions could be classified as progressing (11) or regressing (three). An empirical threshold of 2.0 ml/100 g for CBV allowed detection of regressing lesions with a sensitivity of 100 % and specificity of 100 %. FDG-PET and DCE-MRI agreed in classification of tumor status in 13 out of the 16 cases where an FDG-PET classification was obtained. In two of the remaining three patients, MRI follow-up and histology was available and both indicated that the DCE-MRI answer was correct.
CBV measurements using DCE-MRI may predict the status of contrast enhancing lesions and give results very similar to FDG-PET with regards to differentiation between tumor recurrence and radiation necrosis.
KeywordsBrain tumor DCE T1-Perfusion MRI FDG-PET Radiation necrosis
Arterial input function
Cerebral blood flow
Cerebral blood volume
Dynamic contrast enhanced magnetic resonance imaging
Dynamic susceptibility contrast magnetic resonance imaging
18F-fluorodeoxyglucose positron emission tomography
Internal carotid artery
Region of interest
Conflict of interest
We declare that we have no conflict of interest.
- 4.Dooms GC, Hecht S, Brant-Zawadzki M et al (1986) Brain radiation lesions. MR-imaging Radiology 158:149–155Google Scholar
- 7.Nelson SJ (2011) Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI. NMR in Biomed 24:734–749Google Scholar
- 12.Wang SX, Boethius J, Ericson K (2006) FDG-PET on irradiated brain tumor: ten years’ summary. Acta Radiol : 85–90.Google Scholar
- 15.Ricci PE, Karis JP, Heiserman JE et al (1998) Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR 9:407–413Google Scholar
- 25.Hu LS, Baxter LC, Smith KA et al (2009) Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. Am J Neuroradiol 30:552–558PubMedCrossRefGoogle Scholar
- 26.Barajas R, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S (2009) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 253:486–496PubMedCrossRefGoogle Scholar